Limbic Maturational Changes In Adolescence And Young Adulthood (LIMCA) - A Longitudinal Study
Funder
National Health and Medical Research Council
Funding Amount
$418,897.00
Summary
Structural and cognitive changes of the limbic regions have been linked to number psychiatric disorders. A thorough understanding of the dynamics of healthy maturation of these brain areas with age is necessary. The main aim of this research is to longitudinally study and model the neuro-developmental changes of the limbic region during adolescence and young adulthood. These will provide an invaluable template in identifying deviant patterns of limbic development in children with neuropsychiatri ....Structural and cognitive changes of the limbic regions have been linked to number psychiatric disorders. A thorough understanding of the dynamics of healthy maturation of these brain areas with age is necessary. The main aim of this research is to longitudinally study and model the neuro-developmental changes of the limbic region during adolescence and young adulthood. These will provide an invaluable template in identifying deviant patterns of limbic development in children with neuropsychiatric disorders.Read moreRead less
Low Dose Aspirin And Age-related Macular Degeneration: Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,043,189.00
Summary
Age-related macular degeneration (AMD) is a major cause of visual impairment in advanced countries, responsible for nearly half of all legal blindness in Australia. Due to increased life expectancy, the number of people with this progressive late onset disease will double by 2025. Aspirin could prevent or delay the onset of AMD in older persons but its bleeding risk also needs to be considered. This project will determine whether treatment with low dose aspirin reduces incidence or progression o ....Age-related macular degeneration (AMD) is a major cause of visual impairment in advanced countries, responsible for nearly half of all legal blindness in Australia. Due to increased life expectancy, the number of people with this progressive late onset disease will double by 2025. Aspirin could prevent or delay the onset of AMD in older persons but its bleeding risk also needs to be considered. This project will determine whether treatment with low dose aspirin reduces incidence or progression of AMD.Read moreRead less
The Role Of Reduced Phagocytosis In The Pathogenesis Of Age-related Macular Degeneration
Funder
National Health and Medical Research Council
Funding Amount
$786,742.00
Summary
Understanding the underlying mechanisms which lead to age-related macular degeneration (AMD) is critical if we are to ultimately develop novel treatments. We hypothesise that there is a defective ability to remove debris that accumulates in the retina as we age and this is a crucial step in the development of AMD. We will investigate this hypothesis in an AMD cohort and in a pre-clinical model where we will test the efficacy of an intervention that improves the ability to clear debris.